Hypertriglyceridemia and Cardiovascular Health: Recognizing Risks and Tackling Management

Hypertriglyceridemia and Cardiovascular Health: Recognizing Risks and Tackling Management 

What You Will Learn

Identify the clinical spectrum of HTG encompassing cardiometabolic risk and therapeutic approaches.
Describe multifactorial causes of sHTG and FCS including genetic, medical, drug, and dietary factors.
Describe new treatments for sHTG & FCS that may reduce associated complications, including pancreatitis.
Apply current and emerging therapies within a multidisciplinary care pathway to improve patient outcomes.

Meeting On Demand

We are grateful to these distinguished faculty who contributed to this collection:

Chair

Michael Miller, MD, FACC 

Faculty

Alan S. Brown, MD, FACC
Viet T. Le, PA-C, DMSc, MPAS, FACC
Nicholas A. Marston, MD, MPH

Educational Grant Support Provided By: Ionis Pharmaceuticals

Page Launched: April 2026